177 related articles for article (PubMed ID: 10328037)
1. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis.
Grayston JT; Wang SP
Sex Transm Dis; 1978; 5(2):73-7. PubMed ID: 10328037
[No Abstract] [Full Text] [Related]
2. Immunity to murine chlamydial genital infection.
Morrison RP; Caldwell HD
Infect Immun; 2002 Jun; 70(6):2741-51. PubMed ID: 12010958
[No Abstract] [Full Text] [Related]
3. [The evaluation of the detection of lower urogenital infections by Chlamydia trachomatis in France (Part II) (February 2003)].
ANAES Service d'Evaluation des Technologies and Service d'Evaluation Economique
Gynecol Obstet Fertil; 2004 Jan; 32(1):90-5. PubMed ID: 14736606
[No Abstract] [Full Text] [Related]
4. Sexually transmitted diseases in children: chlamydial oculo-genital infection.
Goh BT; Forster GE
Genitourin Med; 1993 Jun; 69(3):213-21. PubMed ID: 8335315
[No Abstract] [Full Text] [Related]
5. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections.
Kim SK; Angevine M; Demick K; Ortiz L; Rudersdorf R; Watkins D; DeMars R
J Immunol; 1999 Jun; 162(11):6855-66. PubMed ID: 10352308
[TBL] [Abstract][Full Text] [Related]
6. Considerations for the rational design of a Chlamydia vaccine.
Liang S; Bulir D; Kaushic C; Mahony J
Hum Vaccin Immunother; 2017 Apr; 13(4):831-835. PubMed ID: 27835064
[TBL] [Abstract][Full Text] [Related]
7. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study.
Andersen B; Ostergaard L; Møller JK; Olesen F
BMJ; 1998 Jan; 316(7128):350-1. PubMed ID: 9487169
[No Abstract] [Full Text] [Related]
8. Vaccines for Chlamydia infections of the female genital tract.
Hafner LM; McNeilly C
Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
[TBL] [Abstract][Full Text] [Related]
9. Update on Chlamydia trachomatis Vaccinology.
de la Maza LM; Zhong G; Brunham RC
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228394
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of Chlamydia trachomatis antibody response in chlamydial oculogenital infection.
Patel HC; Goh BT; Viswalingam ND; Treharne JD
Genitourin Med; 1995 Apr; 71(2):94-7. PubMed ID: 7744422
[TBL] [Abstract][Full Text] [Related]
11. Urogenital Chlamydia trachomatis infections in general practice: diagnosis, treatment, follow-up and contact tracing.
Andersen B; Ostergaard L; Nygård B; Olesen F
Fam Pract; 1998 Jun; 15(3):223-8. PubMed ID: 9694179
[TBL] [Abstract][Full Text] [Related]
12. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.
Hafner LM; Timms P
Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970
[TBL] [Abstract][Full Text] [Related]
13. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
[TBL] [Abstract][Full Text] [Related]
14. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.
Agrawal T; Vats V; Salhan S; Mittal A
J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206
[TBL] [Abstract][Full Text] [Related]
15. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
Rey-Ladino J; Ross AG; Cripps AW
Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
Su H; Parnell M; Caldwell HD
Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
[TBL] [Abstract][Full Text] [Related]
17. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Brunham RC; Rey-Ladino J
Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia trachomatis during pregnancy. To screen or not to screen?
Carroll JC
Can Fam Physician; 1993 Jan; 39():97-102. PubMed ID: 8435566
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis infection prevalence and serovar distribution in a high-density urban area in the north of Italy.
Foschi C; Nardini P; Banzola N; D'Antuono A; Compri M; Cevenini R; Marangoni A
J Med Microbiol; 2016 Jun; 65(6):510-520. PubMed ID: 27046236
[TBL] [Abstract][Full Text] [Related]
20. Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein.
Olsen AW; Follmann F; Erneholm K; Rosenkrands I; Andersen P
J Infect Dis; 2015 Sep; 212(6):978-89. PubMed ID: 25748320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
